Jasper Therapeutics, Inc.JSPRNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +36.72% | +35.89% | +12.66% | +2.32% | +10.53% |
| Weighted Average Shares Diluted Growth | +36.72% | +35.89% | +12.65% | +2.32% | +10.90% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -9.96% | -15.80% | -54.27% | -59.21% | -42.19% |
| Book Value per Share Growth | -34.98% | -42.14% | -66.88% | -77.10% | -87.49% |
| Debt Growth | -31.35% | -34.92% | +1.45% | -6.95% | -17.69% |
| R&D Expense Growth | -2.65% | +42.91% | +56.89% | +87.64% | -0.44% |
| SG&A Expenses Growth | +20.38% | +41.72% | +25.84% | +25.19% | -12.13% |